کد مقاله کد نشریه سال انتشار مقاله انگلیسی نسخه تمام متن
5629852 1580282 2016 6 صفحه PDF دانلود رایگان
عنوان انگلیسی مقاله ISI
Review articleAngiocentric glioma transformed into anaplastic ependymoma: Review of the evidence for malignant potential
ترجمه فارسی عنوان
بررسی گلیوم آنژین مرکزی به اپندومیوم انعطاف پذیر تبدیل شده است: بررسی شواهدی از پتانسیل بدخیم
موضوعات مرتبط
علوم زیستی و بیوفناوری علم عصب شناسی عصب شناسی
چکیده انگلیسی


- We present a case of angiocentric glioma that transformed into a grade II astrocytoma, and later an anaplastic ependymoma.
- To our knowledge, 83 angiocentric glioma are reported in the literature and these are usually cured with surgery.
- Of the 83 angiocentric glioma, seven have transformed into or been associated with malignant tumours.
- This transformation suggests a malignant potential that could change management.

Angiocentric glioma (AG) is a low grade glioma, that was first described in 2002. Since this description, 83 patients with AG have been described, including ours. AG typically presents in childhood with medically refractory seizures that are cured with gross surgical resection. Whilst the natural history is that of a benign tumour, there have been reports of recurrence, transformation, and malignant features that suggest that AG is potentially malignant. We add to the literature a case of a 16-year-old girl who presented in May 2011 with a 3-month history of complex partial seizures, with MRI showing a T2-weighted hyperintense lesion in the left insula and inferior frontal lobe. This was confirmed on biopsy as AG and was followed with surveillance imaging. In April 2012, she presented with disease progression and underwent a left temporal lobectomy, with histology showing both AG and grade II astrocytoma. Adjuvant radiotherapy of 50 Gray in 28 fractions was administered. A small area of contrast enhancement appeared in the left parietal lobe in December 2012, which progressed over subsequent months. In June 2013, she underwent a near total excision, with histology showing anaplastic ependymoma. She received six cycles of adjuvant temozolamide. Despite this, the tumour continued to progress, with her seizure control deteriorating, and the development of a right hemiparesis. The patient died in January 2014, aged 19 years.

ناشر
Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: Journal of Clinical Neuroscience - Volume 34, December 2016, Pages 47-52
نویسندگان
, , , ,